Align TechnologyXTER:AFW 89 EPS without NRI is €9.43 as of Mar. 2026. GuruFocus rates XTER:AFW with a GF Score™ of 89/100 and a GF Value™ of €205.01 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 664 Medical Devices & Instruments companies, Align Technology ranks better than 53.61% on this metric.
Align Technology's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was €2.23.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was €9.43.
During the past 12 months, Align Technology's average earnings per share (NRI) Growth Rate was 17.60% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 10.60% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 9.00% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 19.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Align Technology's EPS without NRI or its related term are showing as below:
XTER:AFW'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -16.9 Med: 20.2 Max: 232.9
Current: 10.6
During the past 13 years, Align Technology's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 232.90% per year. The lowest was -16.90% per year. And the median was 20.20% per year.
XTER:AFW's 3-Year EPS without NRI Growth Rate is ranked better than 53.61% of 664
companies
in the Medical Devices & Instruments industry
Industry Median: 8.15
vs XTER:AFW: 10.60
Align Technology's EPS (Diluted) for the
three
months ended in Mar. 2026 was €1.36.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €5.13.
Align Technology's EPS (Basic) for the
three
months ended in Mar. 2026 was €1.37.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was €5.14.
Align Technology (XTER:AFW) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Align Technology EPS without NRI Related Terms
Align Technology EPS without NRI Historical Data
* Premium members only.
The historical data trend for Align Technology's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:AFW vs SOLV, COO, BAX: EPS without NRI Comparison
For the Medical Instruments & Supplies subindustry, Align Technology's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Align Technology PE Ratio without NRI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Align Technology's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €9.43
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Align Technology (XTER:AFW) has a EPS without NRI of €9.43 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Align Technology and its competitors. According to the industry distribution chart, Align Technology ranks #308 out of 664 companies in the Medical Devices & Instruments industry, placing it in the top 46.4%.
Is Align Technology's EPS without NRI too high?
Align Technology's current EPS without NRI is €9.43. Based on the distribution chart, Align Technology ranks #308 out of 664 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Align Technology has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Align Technology's EPS without NRI compare to SOLV and COO?
According to the Medical Devices & Instruments industry distribution chart, Align Technology ranks #308 out of 664 companies for EPS without NRI. This puts Align Technology in the upper half of its industry. The industry median EPS without NRI is 8.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.15, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Align Technology and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Align Technology's current EPS without NRI is €9.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Align Technology stock overvalued right now?
Based on GuruFocus' analysis, Align Technology (XTER:AFW) is currently considered Modestly Undervalued. The stock's GF Value™ is €205.01, compared to a current price of €160.85 — trading 21.5% below its estimated fair value. The current EPS without NRI is €9.43. Align Technology's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Align Technology (XTER:AFW), the current EPS without NRI is €9.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Align Technology (XTER:AFW) Overvalued in 2026?
Based on GuruFocus' analysis, Align Technology stock appears to be undervalued.
The current stock price of €160.85 is trading 21.5% below its estimated GF Value™ of €205.01.
GuruFocus considers Align Technology to be Modestly Undervalued.
Key valuation signals for XTER:AFW:
EPS without NRI: €9.43
GF Value™: €205.01 vs. price of €160.85 (21.5% below fair value)
No single metric tells the full story. See the XTER:AFW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
89GF Score
Get the complete analysis for XTER:AFW
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:AFW has been successfully added to your 
